Professor of Radiation Oncology, University Tex Houston
Radiation Oncology
Dr. Thomas A. Buchholz, MD
|
|
Give Review
Doctor Thomas A. Buchholz, MD is an expert in the field of Radiation Oncology. He went to Tufts University School of Medicine. Tufts University School of Medicine is ranked 49 in research and 52 in primary care medicine He has 4 awards "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer" and "Top MD". Doctor Thomas A. Buchholz, MD is a published doctor. He has 99 papers published. The most current publication "Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing."
Publications
- Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance).
- Complications After Mastectomy and Immediate Breast Reconstruction for Breast Cancer: A Claims-based Analysis.
- Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.
- Practical Implications of the Publication of Consensus Guidelines by the American Society for Radiation Oncology: Accelerated Partial Breast Irradiation and the Nation...
- Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy.
- Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique.
- Influence of Neoadjuvant Chemotherapy on Radiotherapy for Breast Cancer.
- Metastatic Tumor Volume and Extranodal Tumor Extension: Clinical Significance in Patients With Stage II Breast Cancer.
- Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at six months compared to conventionally fractionated whole breas...
- Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial.
- Factors associated with radiation therapy incidents in a large academic institution.
- Lobectomy, Sublobar Resection, and Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancers in the Elderly.
- Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
- Physician Variation in Management of Low-Risk Prostate Cancer: A Population-Based Cohort Study.
- Surgeon Influence on Use of Needle Biopsy in Patients With Breast Cancer: A National Medicare Study.
- Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells.
- Simvastatin Radiosensitizes Differentiated and Stem-Like Breast Cancer Cell Lines and Is Associated With Improved Local Control in Inflammatory Breast Cancer Patients ...
- Survival and cost-effectiveness of hospice care for metastatic melanoma patients.
- Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer.
- Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: American Society of Clinical Oncology Endorsement of the ...
- Increasing Use of Advanced Radiation Therapy Technologies in the Last 30 Days of Life Among Patients Dying As a Result of Cancer in the United States.
- Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment.
- Survival of women with inflammatory breast cancer: A large population based study.
- Statistical Modeling Approach to Quantitative Analysis of Interobserver Variability in Breast Contouring.
- Trends and Variation in Use of Breast Reconstruction in Patients With Breast Cancer Undergoing Mastectomy in the United States.
- Improved survival using intensity-modulated radiation therapy in head and neck cancers: A SEER-Medicare analysis.
- Reply to P.G. Tsoutsou et al and O. Kaidar-Person et al.
- Obituary-Kie Kian Ang, MD, PhD, FACR, FASTRO.
- Benefit of Adjuvant Brachytherapy Versus External Beam Radiation for Early Breast Cancer: Impact of Patient Stratification on Breast Preservation.
- Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-hispanic white women aged ≤55 years.
- Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
- Hypofractionated breast radiation: preferred standard of care?
- Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer.
- Determinants of patient satisfaction during receipt of radiation therapy.
- Use of the LQ model with large fraction sizes results in underestimation of isoeffect doses.
- Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits?
- Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: Predictors of use and association with toxicities.
- (18)F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapy.
- Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries.
- Outcomes and Predictive Factors for Salvage Therapy After Local-Regional Recurrence Following Neoadjuvant Chemotherapy and Breast Conserving Therapy.
- Utilization of Surgery, Chemotherapy, Radiation Therapy, and Hospice at the End of Life for Patients Diagnosed With Metastatic Melanoma.
- Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy.
- Radiation Treatments After Breast-Conserving Therapy for Elderly Patients.
- Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy.
- Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy.
- Other Primary Malignancies in Breast Cancer Patients Treated with Breast Conserving Surgery and Radiation Therapy.
- MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation.
- Use of Radiation Therapy in the Last 30 Days of Life Among a Large Population-Based Cohort of Elderly Patients in the United States.
- Evaluating the impact of patient, tumor, and treatment characteristics on the development of jaw complications in patients treated for oral cancers: A SEER-Medicare an...
- Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States.
- Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer.
- The Value of Ultrasound in Detecting Extra-Axillary Regional Node Involvement in Patients with Advanced Breast Cancer.
- Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly.
- Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery.
- Brachytherapy vs Whole-Breast Irradiation: Trial by Data.
- Nomogram to Predict the Benefit of Radiation for Older Patients With Breast Cancer Treated With Conservative Surgery.
- Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy.
- Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer.
- Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.
- Poly (ADP-ribose) Polymerase Inhibitors in Cancer Treatment.
- Identifying factors that impact survival among women with inflammatory breast cancer.
- Hazard of Recurrence among Women after Primary Breast Cancer Treatment - A 10-Year Follow-Up Using Data from SEER-Medicare.
- Gamma-ray-induced mutagen sensitivity and risk of sporadic breast cancer in young women: a case-control study.
- Topical Hyaluronic Acid vs. Standard of Care for the Prevention of Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer: Single-Blind Randomized Phase II...
- Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer.
- Novel Staging System for Predicting Disease-Specific Survival in Patients With Breast Cancer Treated With Surgery As the First Intervention: Time to Modify the Current...
- Improvement in breast cancer outcomes over time: are older women missing out?
- Positive Sentinel Nodes Without Axillary Dissection: Implications for the Radiation Oncologist.
- Breast conservation therapy in the 21st century.
- Local-Regional Recurrence With and Without Radiation Therapy after Neoadjuvant Chemotherapy and Mastectomy for Clinically Staged T3n0 Breast Cancer.
- Occult axillary lymph node metastasis do not have prognostic significance in early stage breast cancer.
- Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence After Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy.
- Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers.
- MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells.
- Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome.
- Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women.
- Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer.
- Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impac...
- Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.
- A Population-Based Study of the Quality of Care in the Diagnosis of Large (≥5 cm) Soft Tissue Sarcomas.
- Adoption of Intensity-Modulated Radiation Therapy for Breast Cancer in the United States.
- Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-posi...
- Validation of a Novel Staging System for Disease-Specific Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy.
- Cardiac Motion During Deep-Inspiration Breath-Hold: Implications for Breast Cancer Radiotherapy.
- Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.
- Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing T...
- A Multidisciplinary Protocol for Planned Skin-Preserving Delayed Breast Reconstruction for Patients with Locally Advanced Breast Cancer Requiring Postmastectomy Radiat...
- Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care.
- The impact of age on outcome in early-stage breast cancer.
- Long-Term Outcomes in Patients with Isolated Supraclavicular Nodal Recurrence After Mastectomy and Doxorubicin-Based Chemotherapy for Breast Cancer.
- The future of radiation oncology in the United States from 2010 to 2020: will supply keep pace with demand?
- Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation.
- Radiation Therapy After Breast-Conserving Surgery: Does Hospital Surgical Volume Matter? A Population-Based Study in Taiwan.
- Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.
- Population-based analysis of occult primary breast cancer with axillary lymph node metastasis.
- External-Beam Accelerated Partial Breast Irradiation Using Multiple Proton Beam Configurations.
- Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer.
- Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
Schools
Tufts University School Of Medicine
Mt Auburn Hospital
University of Washington
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Top MD
Education
-
University of Washington -
Tufts University School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Helpful Reviews
Similar Doctors
|
Dr. Hsin H. Lu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew K. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel R. Gomez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph S. Kong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle S. Ludwig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ali Mazloom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mirna Abboud, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark A. Edson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack Phan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cameron H. Swanick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan Verma, MD
This Doctor is OpenDoctor Recommended.
|